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Abstract
Background: Recent, dramatic increases in coronary heart disease (CHD) mortality in China can
be mostly explained by adverse changes in major cardiovascular risk factors. Our study aimed to
assess the potential impact of subsequent changes in risk factors and population ageing on CHD
deaths in Beijing between 1999 and 2010.
Methods:  The previously validated IMPACT model was used to estimate the CHD deaths
expected in 2010, with treatment uptakes being held constant at levels measured in 1999,
comparing three scenarios: a) taking into account the ageing of the population but assuming no
further changes in major risk factor levels from 1999 or, b) if recent risk factor trends continued
until 2010 or, c) if there was a 0.5% annual reduction in each risk factor.
Results: Population ageing alone would result in approximately 1990 additional deaths in 2010
compared with 1999, representing an increase of 27%. Continuation of current risk factor trends
would result in approximately 3,015 extra deaths in 2010, [a 40% increase]; three quarters of this
increase would be attributable to rises in total cholesterol levels. Thus, demographic changes and
worsening risk factors would together result in a 67% increase in CHD deaths. Conversely,
assumed 0.5% annual reductions in risk factors (a mean population level decline of 0.3 mmol/L for
total cholesterol in both genders, and smoking prevalence declining by 3.0% for men and 4.1% for
women, body mass index by 1.3 kg/m2 for men and 1.4 kg/m2 for women, diabetes prevalence by
0.4% in both genders, and diastolic blood pressure by 4.7 mmHg for men and 4.4 mmHg for
women) would result in some 3,730 fewer deaths, representing a 23% decrease overall. These
findings remained consistent in sensitivity analyses.
Conclusion: CHD death rates are continuing to rise in Beijing. This reflects worsening risk factor
levels, compounded by demographic trends. However, the adverse impact of population ageing on
CHD burden could be completely offset by eminently feasible improvements in diet and smoking.
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Background
Coronary heart disease (CHD) mortality rates have halved
in most industrialized countries since the 1980s [1]. How-
ever, most developing countries, including China, have
experienced substantial increases in CHD mortality in
recent decades [2]. CHD is thus projected to be the lead-
ing global cause of death and disability by 2020 [3].
A variety of CHD policy models have therefore been
developed to help explain the observed changes in CHD
mortality in terms of changes in cardiovascular risk factors
and treatments [4-6]. Analyses conducted in different
countries have consistently suggested that reductions in
cardiovascular risk factors account for larger CHD mortal-
ity effects than treatments [7-14]. Using these models to
explain future trends in CHD mortality in terms of risk
factor trends, or demographic change, can be potentially
helpful for policy makers. Such analyses can also help
identify the most effective and cost-effective prevention
strategies, especially for economically developing coun-
tries.
The IMPACT Model was developed by Capewell and col-
leagues and successfully used to help explain the observed
declines in CHD mortality resulting from improving risk
factor levels and cardiological treatments in many devel-
oped countries, including the UK, the USA, New Zealand
and Finland [9-13,15], and to estimate the number of
additional deaths that could be prevented or postponed
due to further declines in risk factors [16]. Subsequently,
the model was used to evaluate potential future options
[9-13,17]. More recently, the IMPACT model has also
been applied to populations where CHD mortality rates
are increasing [18]. In Beijing between 1984 and 1999,
the CHD mortality rates rose by 50% in men and 27% in
women aged 35–74 years, and most of these increases
could be attributed to substantial increases in total choles-
terol levels (mean population level rose by 1.1 mmol/L)
[18].
In this paper, we now extend this Beijing population
model from 1999 to estimate the number of CHD deaths
anticipated in Beijing in 2010 under three contrasting sce-
narios: a) assuming simple population ageing, b) assum-
ing that recent adverse trends in risk factors continue to
worsen, and c) more optimistically assuming 0.5%
annual reductions in major cardiovascular risk factors, as
already achieved in many other populations [17]. These
estimates might provide a potentially useful reference to
inform the planning of future CHD prevention and treat-
ment strategies in Beijing.
Methods
Identification of relevant data
The model includes information on mortality and risk fac-
tor trends in the Beijing population aged 35–74 years.
Data on the population size and gender- and age-specific
CHD mortality were obtained from the fifth National
Population Census (2000) and Beijing Municipal Bureau
of Statistics [19]. The number of CHD deaths in 1999 was
therefore calculated by applying the mortality and popu-
lation size by gender and age group for Beijing. The pro-
jected population estimates in 2010 were provided by the
Chinese Statistics Association. The changes in population
size between 1999 and 2010 are listed in Table 1. Five
independent cardiovascular risk factor surveys were car-
ried out in the stratified-random sampling subjects from
MONICA monitoring population in Beijing from 1984–
1999. Trends of major cardiovascular risk factors were
compared, including systolic and diastolic blood pres-
sure, prevalence of hypertension, serum total cholesterol,
glucose, body mass index and smoking prevalence. Popu-
lation risk factor trend data came from these quality-
assured MONICA and Sino-MONICA studies [20-22].
This IMPACT Model uses two validated methods to
describe the relationships between population changes in
specific cardiovascular risk factors and the consequent
changes in population CHD mortality rates [5,11,18]. The
first is a regression method. (More detailed information is
provided in Additional file 1).
1) Regression coefficients from meta-analyses of large
cohort studies were used to assess the mortality effects of
changes in cholesterol [23,24], body mass index (BMI)
[25] and diastolic blood pressure [26]. The subsequent
additional deaths, stratified by age and gender, were cal-
culated as the product of the number of CHD deaths
observed in 1999 (the base year), the absolute risk factor
change and the regression coefficient.
2) Alternatively, another separate method was used in the
absence of suitable β-coefficient, and also as an independ-
ent validation. Population attributable risk fractions
(PARF) were used to assess the effects of changes in smok-
ing and diabetes prevalence. The mortality outputs were
estimated as the product of the CHD deaths in the base
year (1999), multiplied by the increase in PARF between
1999 and 2010. The mortality changes expected from the
trends in each risk factor were obtained from Chinese
cohort studies (smoking [27,28]) and meta-analyses of
large cohort studies (diabetes [29,30]). Since there have
been substantial recent changes in both the level and prev-
alence of smoking in China, the impact of smoking was
modeled as three categories based on cigarette consump-
tion (cigarettes/day: 1–9, 10–19, and ≥ 20).
The  β-coefficients and relative risk were derived from
studies in America, Europe and Asia, and more than ten
cohort studies conducted in mainland China. The number
of participants ranged from 44 to 49,000, and 1%–64%
were women. The age range of participants was 35–89BMC Public Health 2009, 9:30 http://www.biomedcentral.com/1471-2458/9/30
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years old, and the duration of follow-up was from 3.0 to
21.2 years (see Additional file 1).
Estimating the number of CHD deaths in 2010
Scenario 1: Simply assuming population ageing between 1999 and 
2010
The deaths expected in 2010 were calculated by indirect
age standardization, applying the age-specific death rates
in 1999 to the 2010 projected population. This therefore
assumed no change in age and gender-specific CHD mor-
tality rates between 1999 and 2010.
Scenario 2: Continuation in recent risk factor trends between 1999 
and 2010
All the major risk factors (smoking prevalence, total cho-
lesterol level and diastolic blood pressure) showed
upward trends for both genders from 1984 to 1999,
except for smoking prevalence in women, as measured in
quality-assured MONICA and Sino-MONICA studies, and
serial national surveys [20-22]. In this scenario, we there-
fore assumed that the recent trends in risk factor levels
observed in Beijing population between 1984–1999 sim-
ply continued at the same relative rates until 2010. In the
absence of detailed trend data in the elderly, we conserva-
tively assumed that the risk factor changes in the older
population aged 65–74 years rose at only half the rate of
the increases seen in younger age groups [17]. The
observed risk factor levels in 1999 and those projected in
2010 among subjects aged 35–64 years are detailed in
Table 2.
Scenario 3: Optimistically assuming 0.5% annual risk factor 
reductions between 1999 and 2010
Similar calculations were then performed, more optimis-
tically assuming 0.5% annual reductions in cholesterol,
diastolic blood pressure, BMI and diabetes prevalence in
both genders. Similar rates of reduction have been
achieved in other rapidly industrializing populations, e.g.
Poland, the Czech Republic and Hungary [31]. Smoking
prevalence has already fallen in women in Beijing, and it
also now appears to be falling nationally in men.
Treatment trends
All medical and surgical treatment uptakes in the present
study were held constant at levels measured in 1999,
reflecting current resource constraints. These levels, and
Table 1: Gender- and age-specific population sizes in Beijing in 1999 and projections to 2010
Groups 1999 2010 % population increase
Men
35–44 1,402,305 1,330,195 -5.1
45–54 899,529 1,351,654 50.3
55–64 506,847 841,221 66.0
65–74 410,002 426,058 3.9
Total men 3,218,683 3,949,128 22.7
Women
35–44 1,249,534 1,134,015 -9.2
45–54 883,857 1,258,104 42.3
55–64 557,514 875,272 57.0
65–74 412,808 499,409 21.0
Total women 3,103,715 3,766,800 21.4
Men & Women 6,322,396 7,715,928 22.0BMC Public Health 2009, 9:30 http://www.biomedcentral.com/1471-2458/9/30
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the data sources on which they were based, have been
described previously [18].
Sensitivity analysis
Most model parameters were subject to some uncertainty,
with potential overestimation or underestimation of ben-
efit. Sensitivity analyses were therefore performed using
the analysis of extremes method [5,11]. In addition to the
'best' estimate of mortality change, minimum and maxi-
mum estimates were also generated using the highest and
lowest plausible values for each risk factor.
Study ethics
This study design and investigation were ethically
approved by the ethical committee of Beijing Anzhen
Hospital affiliated to the Capital Medical University.
Results
Changes in the population structure between 1999 and 
2010
The gender- and age-specific characteristics of the popula-
tion in the base year and final year are summarized in
Table 1. The population size will increase by approxi-
mately 23% for men and 22% for women aged 35–74
years. The estimated age-specific percentage increases in
the age groups of 35–44, 45–54, 55–64 and 65–74 years
between 1999 and 2010 would be -5%, 50%, 66% and
4%, respectively, in men, and -10%, 43%, 57% and 21%,
respectively, in women, reflecting current demographic
changes in the Beijing population.
Estimated CHD deaths in 2010
Scenario 1: Simply due to demographic changes
Simply assuming that the age-specific death rates in 1999
continue to apply to the older population in 2010,
approximately 9,390 CHD deaths would be expected in
2010 (5,565 among men and 3,825 in women, represent-
ing overall increases of 24.2% and 31.0% from 1999,
respectively).
Scenario 2: Based on the current risk factor trends
A projection of the recent trends indicated that risk factors
would continue to increase from 1999, as detailed in
Table 2. This would lead to approximately 3,015 extra
CHD deaths in 2010, (minimum estimate 1,922, maximum
estimate 4,376, Figure 1. Black diamond indicates the best
estimate, and short bar the minimum and maximum esti-
mates). These 3,015 additional deaths would result from
approximately 2,265 (75%) attributable to increases in
total cholesterol level (from 5.3 mmol/L to 5.8 mmol/L),
approximately 510 attributable to an increased prevalence
of diabetes (from 7.1% to 15.8%), approximately 140
attributable to increase in BMI (from 25.1 to 26.0),
approximately 55 additional deaths attributable to a
slight increase in diastolic blood pressure (from 83.5
mmHg to 84.1 mmHg), and approximately 50 attributa-
ble to an overall increase in smoking prevalence in men
(from 58.0% to 68.6%) but a decrease in women (from
8.9% to 4.8%).
Scenario 3: Optimistic assumption: small reductions in risk factors
A total of approximately 3,730 CHD deaths (minimum
estimate 2,180, maximum estimate 5,499) may be pre-
vented or postponed by modest but feasible reductions in
each major risk factor. The biggest benefits would come
from decreases in the total cholesterol levels, followed by
decreases in the mean population diastolic blood pressure
and smoking rates (Figure 2. Black diamond indicates the
best estimate, and short bar the minimum and maximum esti-
mates). The specific results are detailed below.
Table 2: Risk factor levels at 1999 baseline and projections to 2010 for men and women aged 35–64 years*
Risk factors 1999 (baseline) 2010 (assuming current trends continue) 2010 (assuming 0.5% annual reductions)
men women men women men women
Cholesterol (mmol/L) 5.3 5.3 5.8 5.9 5.0 5.0
Smoking (prevalence) 58.0% 8.9% 68.6% 4.8% 52.0% 4.8%†
BMI (kg/m2) 25.1 25.1 26.8 25.1 23.8 23.7
Diabetes (prevalence) 7.1% 7.2% 17.2% 14.4% 6.7% 6.8%
Diastolic blood pressure 
(mmHg)
85.9 80.9 86.3 81.7 81.2 76.5
BMI indicates body mass index
* Risk factor changes in the older population aged 65–74 years, where data was generally lacking, were conservatively assumed to rise at half the 
rate of the increases seen in younger age groups (data for this age group not shown in table).
† Recent trends already represent an annual fall of approximately 0.5%.BMC Public Health 2009, 9:30 http://www.biomedcentral.com/1471-2458/9/30
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First, approximately 1,445 fewer deaths (minimum 705,
maximum 2,440) if the mean population cholesterol lev-
els fell from 5.3 mmol/L to 5.0 mmol/L in both men and
women.
Second, approximately 510 fewer deaths (minimum 151,
maximum 814) if the smoking rates fell from 58.0% to
52.0% in men and from 8.9% to 4.8% in women.
Third, approximately 215 fewer deaths (minimum 121,
maximum 313) if the mean population BMI fell from 25.1
kg/m2 to 23.8 kg/m2 in men and from 25.1 kg/m2 to 23.7
kg/m2 in women.
Fourth, approximately 125 fewer deaths (minimum 77,
maximum 141) if the population diabetes prevalence fell
from 7.1% to 6.7% in men and from 7.2% to 6.8% in
women.
Fifth, approximately 1,440 fewer deaths (minimum 1,126,
maximum 1,791) if the mean population diastolic blood
pressure level fell from 85.9 mmHg to 81.2 mmHg in
men and from 80.9 mmHg to 76.5 mmHg in women.
Mortality changes by age and gender
Changes in population-based mortality rates during
1999–2010 under the three contrasting scenarios are
detailed in Table 3. Overall, a larger mortality decrease
would be seen in men (approximately 2,355 DPPs) than
in women (approximately 1,370 DPPs). In women, the
biggest benefits would come from improved cholesterol
levels, followed by improved diastolic blood pressure and
a decreased smoking rate. Whereas in men, the biggest
benefits would come from improved diastolic blood pres-
sure and cholesterol level, followed by improvements in
smoking rates (Figure 3. Black diamond indicates the best
estimate, and short bar the minimum and maximum esti-
mates).
More benefits would be gained in the youngest age groups
in both genders (Table 3).
Sensitivity analyses
The principal results remained stable in the sensitivity
analysis. (Figures 1, 2, 3, 4. Black diamond indicates the best
estimate, and short bar the minimum and maximum esti-
mates). Figure 3 shows the sensitivity analysis for Scenario
3. Thus, irrespective of whether best, minimum or maxi-
CHD mortality trends in Beijing 1999–2010: extra deaths attributable to increases in risk factors: results of a sensitivity analysis Figure 1
CHD mortality trends in Beijing 1999–2010: extra deaths attributable to increases in risk factors: results of a 
sensitivity analysis.
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mum estimates were considered, modest reductions in
cholesterol were likely to decrease mortality more than
comparable reductions in smoking, diabetes or obesity
(Figure 3).
Discussion
This study analyzed current trends in risk factor levels and
population ageing to estimate the number of CHD deaths
expected in the Beijing population by 2010. Compared
with 1999, approximately 1,990 additional deaths might
be expected simply due to population ageing, represent-
ing a 27% increase. Most worryingly, if recent adverse
trends in major risk factors also continue, Beijing will
experience over 12,000 CHD deaths in 2010, representing
a 67% increase. Alternatively, if modest reductions in
major risk factors (0.5% per year) were achieved, as in
many other countries, these reductions would decrease
CHD deaths by approximately 23%, in spite of popula-
tion ageing (Figure 2).
The impact of population ageing on CHD mortality was
very obvious in this study. In 2010, a substantial increase
in older people (about 1.4 million more citizens aged 35–
74 years) is expected in Beijing, representing an increase
of approximately 22%. Even if the risk factor profiles and
treatments remain as good as they were in 1999, these
demographic trends mean that the projected CHD deaths
in 2010 will rise above 9,300, representing a 27% increase
compared with 1999. The number of elderly women is
projected to increase far more substantially than the
number of elderly men, resulting in a particularly large
mortality burden in women. This gender difference is
partly explained by a differential mortality in men from
competing causes at earlier ages (mainly due to their very
high smoking prevalence) [32,33]. Conversely, CHD
deaths in the youngest age groups will decrease due to
their decline in population size (attributable to a reduc-
tion in the birth rate since 1975) [34].
Although several studies have examined the decline in
CHD mortality in Western countries [7,9-13], very few
studies have been conducted in developing countries or in
Asia [18,35,36]. Beijing has witnessed a dramatic increase
in CHD mortality during recent decades, much of which
can be attributed to the rising population cholesterol lev-
els [18]. Furthermore, the incidence rate of CHD showed
a corresponding upward trend in Beijing during 1987 to
1993 [20]. Similarly, the CHD epidemic in Singapore can
be largely explained by higher cholesterol levels [35].
These trends are consistent with the observed changes
CHD mortality trends in Beijing 1999–2010: deaths prevented or postponed by reductions in risk factors: results of a sensitiv- ity analysis Figure 2
CHD mortality trends in Beijing 1999–2010: deaths prevented or postponed by reductions in risk factors: 
results of a sensitivity analysis.
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from traditional to Western diet [37], with a higher con-
sumption of dietary saturated fat and lower consumption
of polyunsaturated fats, vegetables and carbohydrates
[35]. If the recently observed adverse trends in risk factors
levels continue in Beijing, there would be 3,000 more
deaths annually by 2010 than otherwise expected based
on demographic trends (population ageing) alone.
Impressively, approximately three-quarters of this
increase would reflect increases in total cholesterol levels.
In the mid-1980s, cholesterol and obesity levels in Beijing
were the lowest among all the MONICA populations [38].
However, the subsequent massive increases in cardiovas-
cular risk factor levels, especially cholesterol, have
resulted in many additional CHD deaths because choles-
terol is a particularly powerful CHD risk factor [18,38].
Intriguingly, in Japan, decreasing CHD mortality rates
have been reported despite modest increases in the total
cholesterol levels and similarly high smoking rates to Bei-
jing. However, the high consumption of cardioprotective
oily fish in Japan may have helped to offset the unfavour-
able effects of other cardiovascular risk factors [36]. In Bei-
jing, the overall population diastolic blood pressure level
increased slightly and made only a small contribution to
the predicted change in CHD mortality. Improvements in
hypertension treatment may have contributed [18,39].
Modest reductions in major risk factors could hugely
affect the number of future CHD deaths in Beijing, despite
population ageing. Annual 0.5% reductions in major risk
factors could result in some 3,730 fewer deaths in 2010,
representing a 23% decrease compared with 1999. Effec-
tive strategies targeting modifiable risk factors could there-
fore partly offset the adverse impact of unmodifiable risk
factors, the most powerful being age.
Small but powerful risk factor reductions have actually
been observed elsewhere [17]. Similarly modest falls in
the smoking rate, cholesterol level and blood pressure
have all been achieved in other industrializing popula-
tions, such as Poland and the Czech Republic [31], and
thus appear to be feasible in Beijing. Encouragingly, a cit-
ywide public smoking ban was enacted in Beijing in 1996,
and a nationwide survey confirmed that the smoking rates
in China have fallen in recent years [40]. The signing of
the Framework Convention on Tobacco Control by the
government of China will further promote reductions in
smoking. However, reductions in obesity and diabetes
Contribution of 0.5% annual reductions in risk factors to the projected CHD death reduction in Beijing by gender, 1999 to  2010: results of a sensitivity analysis Figure 3
Contribution of 0.5% annual reductions in risk factors to the projected CHD death reduction in Beijing by gen-
der, 1999 to 2010: results of a sensitivity analysis.
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appear more challenging to achieve, with adverse trends
continuing in the USA and Western Europe [41]. Further-
more, even if the proposed modest reductions in smoking
and blood pressure were actually achieved by 2010, the
levels in Beijing would remain higher than in most other
countries [12,17,38,42]. There is clearly a need for further,
more substantial reductions in smoking and blood pres-
sure levels. Such declines would be expected to greatly
reduce the burden of CHD [43].
This modeling work can provide useful information, pro-
mote evidence-based health policy making, and improve
Table 3: Gender- and age-specific changes in population-based mortality rates during 1999–2010 with current risk factor trends or 0.5% 
annual reductions in each risk factor
Age groups Men Women
Death rates(1/100000) % change (%) (1999–2010) Death rates(1/100000) % change (%) (1999–2010)
35–44 years
Rate in 1999 31.6 - 7.9 -
i) Current trend 40.4 27.8 7.8 -1.3
ii) 0.5% reduction 14.7 -53.5 3.9 -50.6
45–54 years
Rate in 1999 71.1 - 27.0 -
i) Current trend 103.8 46.0 38.9 44.1
ii) 0.5% reduction 43.3 -39.1 18.0 -33.3
55–64 years
Rate in 1999 207.2 - 135.1 -
i) Current trend 293.4 41.6 204.5 51.4
ii) 0.5% reduction 137.2 -33.8 92.5 -31.5
65–74 years
Rate in 1999 572.2 - 442.6 -
i) Current trend 601.6 5.1 613.7 39.6
ii) 0.5% reduction 298.8 -47.8 274.9 -37.9
TOTAL (all ages)
Rate in 1999 139.2 - 94.0 -
i) Current trend 176.5 26.8 144.2 53.4
ii) 0.5% reduction 81.2 -41.7 65.1 -30.7
Positive value indicates an increase in mortality, and negative value a decrease.BMC Public Health 2009, 9:30 http://www.biomedcentral.com/1471-2458/9/30
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the effectiveness of prevention strategies. Our study results
showed that there is substantial potential benefit from
reductions in major cardiovascular risk factors by modify-
ing lifestyle, even with the growing and ageing popula-
tion. The achievable interventions targeting these major
risk factors could produce substantial declines of coronary
mortality, as already achieved elsewhere [44].
Like any forecasting tool, this study has a number of
strengths including the use of a transparent modelling
methodology previously replicated in a range of popula-
tions. It also contains a number of limitations. Firstly, it
considers only mortality, but not years of life lost or mor-
bidity. Life expectancy or life-years gained should be
included in future versions of this model [43,45,46]. Sec-
ondly, potential interactions among risk factors and
potential lag effects were not considered in this compara-
tively simple, cell-based model. Thus, four important
assumptions were made in the model. Firstly, that by
using independent coefficients from multivariate analy-
ses, reducing one risk factor would not affect another one.
In reality, multiplicative interactions between various risk
factors may further decrease the CHD risk [47]. Secondly,
assuming an immediate CHD mortality benefit from risk
factor modifications. In reality, delay might be surpris-
ingly short. Thus, the relative risk of CHD death declines
by approximately 37% at 1 year after quitting smoking
[48]. Furthermore, the surprisingly rapid CHD mortality
reversals seen in Poland, Hungary and the Czech Republic
[attributed to dietary changes] have recently been mir-
rored in communities adopting smoke-free legislation
[49-51]. Thirdly, we considered only CHD deaths, not
"competing causes" [52]. However, reductions in major
risk factors would actually decrease deaths from other
non-CHD causes, such as diabetes and common cancers
[53]. Fourthly, the treatment uptakes in 2010 were
assumed to remain constant at levels measured in 1999.
In fact, more substantial improvements may be antici-
pated [18,54]. Our model estimates should therefore not
be viewed as precise projections, but are usefully indica-
tive of the changes in CHD mortality rates which might be
expected under our three alternative scenarios.
Conclusion
In conclusion, without specific interventions, a substan-
tial increase in CHD deaths in Beijing is likely to occur.
This will reflect worsening risk factors compounded by
population ageing. However, modest, but eminently
achievable, improvements in major risk factors could
actually decrease the CHD burden. Future prevention
Summary of observed CHD deaths in 1999 and projections to 2010 under the three contrasting scenarios: results of a sensitiv- ity analysis Figure 4
Summary of observed CHD deaths in 1999 and projections to 2010 under the three contrasting scenarios: 
results of a sensitivity analysis.
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strategies clearly need to be substantially strengthened.
Furthermore, these results may be cautiously generaliza-
ble to other middle income countries addressing their
own cardiovascular disease epidemics.
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